Nanzer, Alexandra M <br/><br/>
Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  Aug 2013 
 - 297-304.e3 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6825 
<br/><br/><label>Standard No.: </label>10.1016/j.jaci.2013.03.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Asthma--drug therapy<br/>Cells, Cultured<br/>Drug Resistance<br/>Female<br/>Glucocorticoids--pharmacology<br/>Humans<br/>Interleukin-10--biosynthesis<br/>Interleukin-17--biosynthesis<br/>Interleukins--biosynthesis<br/>Leukocytes, Mononuclear--immunology<br/>Lymphocyte Activation<br/>Male<br/>Real-Time Polymerase Chain Reaction<br/>Severity of Illness Index<br/>Th17 Cells--immunology<br/>Up-Regulation<br/>Vitamin D--analogs & derivatives<br/>Interleukin-22